AI Summary
✦ ClarthaValuation Metrics
Trading 6.0% below historical median. Valuation is stable — currently in the undervalued zone (z-score: -0.21). Confidence: 50%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
0.49
Current
0.47
Overvalued
0.57
Undervalued
0.42
5Y Average
—
Current
6.48
Overvalued
7.45
Undervalued
5.51
5Y Average
0.89
Current
0.41
Overvalued
1.02
Undervalued
0.76
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.8x Undervalued | -47% vs avg | -4.8% |
FINEOTEX CHEMICAL LIMITED FCLSpecialty Chemicals | +174.8% | 12.1% | 104.9x Premium | +106% vs avg | +86.4% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.3x Premium | +54% vs avg | +6.9% |
JUBILANT INGREVIA LIMITED JUBLINGREASpecialty Chemicals | +25.3% | 6.6% | 37.6x Undervalued | -26% vs avg | +6.4% |
ALKYL AMINES CHEM. LTD ALKYLAMINESpecialty Chemicals | -4.6% | 11.8% | 44.4x Fair | -13% vs avg | -7.6% |
CLEAN SCIENCE & TECH LTD CLEANSpecialty Chemicals | +10.5% | 23.7% | 36.9x Undervalued | -28% vs avg | -30.7% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.1x Undervalued | -47% vs avg | -11.6% |
KIRI INDUSTRIES LIMITED trades at a discount (0.5x vs peer avg 50.9x), suggesting potential undervaluation relative to the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, FINEOTEX CHEMICAL LIMITED, ANUPAM RASAYAN INDIA LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹241 CrMar 2026Latest net profit
₹513 CrMar 2026Latest EPS
₹85.49Mar 2026Net margin
-55.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 157 | 141 | 151 | 141 | 200 | 168 | 145 | 156 | 186 | 181 | 195 | 162 | 241 |
| Expenses + | 172 | 154 | 170 | 162 | 210 | 168 | 151 | 202 | 178 | 197 | 209 | 209 | 374 |
| Operating Profit | -15 | -13 | -19 | -21 | -11 | -0 | -6 | -46 | 8 | -17 | -14 | -47 | -133 |
| OPM % | -10% | -9% | -12% | -15% | -5% | -0.3% | -3.9% | -29% | 4.5% | -9% | -7% | -29% | -55% |
| Other Income + | 1 | 25 | 0 | 8 | 3 | 14 | 3 | 83 | 5 | 34 | 4 | 5,959 | 59 |
| Interest | 2 | 4 | 5 | 6 | 8 | 5 | 8 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 11 |
| Profit before tax | -27 | -2 | -35 | -30 | -26 | -3 | -22 | 24 | 1 | 5 | -22 | 5,899 | -86 |
| Tax % | -1% | -45% | -2% | -3% | 11% | -37% | -5% | -5% | -37% | -40% | -5% | 14% | -700% |
| Net Profit + | -27 | -1 | -34 | -29 | -29 | -2 | -21 | 25 | 2 | 7 | -21 | 5,082 | 513 |
| EPS in Rs | -5.13 | -0.25 | -6.59 | -5.60 | -5.62 | -0.33 | -4.06 | 4.57 | 0.32 | 1.29 | -3.52 | 846.63 | 85.49 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On 30/06/2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018